Evidence for population-based BRCA1 and BRCA2 screening for ovarian cancer prevention

被引：0
|
作者：
Levy-Lahad, E. [1 ]
Gabai-Kapara, E. [1 ]
Kaufman, B. [2 ]
Catane, R. [2 ]
Segev, S. [3 ]
Renbaum, P.
Beller, U. [4 ]
King, M. C. [5 ,6 ]
Lahad, A. [7 ]
机构：
[1] Hebrew Univ Jerusalem, Sch Med, Inst Med Genet, Shaare Zedek Med Ctr, IL-91010 Jerusalem, Israel
[2] Chaim Sheba Med Ctr, Div Oncol, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Inst Med Screening, IL-52621 Tel Hashomer, Israel
[4] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel
[5] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA
[6] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[7] Hebrew Univ Jerusalem, Sch Med, Dept Family Med, IL-91010 Jerusalem, Israel
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2012年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
    Gabai-Kapara, Efrat
    Lahad, Amnon
    Kaufman, Bella
    Friedman, Eitan
    Segev, Shlomo
    Renbaum, Paul
    Beeri, Rachel
    Gal, Moran
    Grinshpun-Cohen, Julia
    Djemal, Karen
    Mandell, Jessica B.
    Lee, Ming K.
    Beller, Uziel
    Catane, Raphael
    King, Mary-Claire
    Levy-Lahad, Ephrat
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (39) : 14205 - 14210
  • [2] Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: A call for evidence
    Levy-Lahad, Ephrat
    GENETICS IN MEDICINE, 2009, 11 (09) : 620 - 621
  • [3] Population-Based Screening for BRCA1 and BRCA2 2014 Lasker Award
    King, Mary-Claire
    Levy-Lahad, Ephrat
    Lahad, Amnon
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (11): : 1091 - 1092
  • [4] Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers
    Synowiec, Agnieszka
    Wcislo, Gabriel
    Bodnar, Lubomir
    Gasowska-Bodnar, Agnieszka
    Szczylik, Cezary
    GINEKOLOGIA POLSKA, 2014, 85 (05) : 377 - 381
  • [5] Population-Based Genetic Testing for BRCA1 and BRCA2
    Narod, Steven
    Akbari, Mohammad R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) : 517 - +
  • [6] A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer
    Lu, KH
    Cramer, DW
    Muto, MG
    Li, EY
    Niloff, J
    Mok, SC
    OBSTETRICS AND GYNECOLOGY, 1999, 93 (01): : 34 - 37
  • [7] BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland:: a population-based study
    Rafnar, T
    Benediktsdottir, KR
    Eldon, BJ
    Gestsson, T
    Saemundsson, H
    Olafsson, K
    Salvarsdottir, A
    Steingrimsson, E
    Thorlacius, S
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (18) : 2788 - 2793
  • [8] Turkish population-based screening for first identified changes of BRCA1 and BRCA2 genes in breast and/or ovarian cancer patients
    Sevimli, Tugba Semerci
    Sevimli, Murat
    Manguoglu, Ayse Esra
    Luleci, Guven
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2024, 25 (01)
  • [9] The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
    Ramus, Susan J.
    Gayther, Simon A.
    MOLECULAR ONCOLOGY, 2009, 3 (02) : 138 - 150
  • [10] Inactivation of BRCA1 and BRCA2 in ovarian cancer
    Hilton, JL
    Geisler, JP
    Rathe, JA
    Hattermann-Zogg, MA
    DeYoung, B
    Buller, RE
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (18): : 1396 - 1406
12345